A detailed history of Mwg Management Ltd. transactions in Lyell Immunopharma, Inc. stock. As of the latest transaction made, Mwg Management Ltd. holds 1,008,116 shares of LYEL stock, worth $10.7 Million. This represents 17.17% of its overall portfolio holdings.

Number of Shares
1,008,116
Previous 20,162,332 95.0%
Holding current value
$10.7 Million
Previous $10.9 Million 18.15%
% of portfolio
17.17%
Previous 18.54%

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2025

Aug 14, 2025

SELL
$0.39 - $13.47 $7.47 Million - $258 Million
-19,154,216 Reduced 95.0%
1,008,116 $8.91 Million
Q4 2021

Feb 14, 2022

SELL
$7.13 - $15.19 $971,034 - $2.07 Million
-136,190 Reduced 0.67%
20,162,332 $156 Million
Q3 2021

Nov 15, 2021

SELL
$11.0 - $17.95 $337,843 - $551,298
-30,713 Reduced 0.15%
20,298,522 $300 Million
Q2 2021

Aug 16, 2021

BUY
$15.99 - $16.89 $325 Million - $343 Million
20,329,235 New
20,329,235 $330 Million

Others Institutions Holding LYEL

About Lyell Immunopharma, Inc.


  • Ticker LYEL
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 247,824,992
  • Market Cap $2.62B
  • Description
  • Lyell Immunopharma, Inc., a T cell reprogramming company, engages in developing T cell therapies for patients with solid tumors. The company develops therapies using technology platforms, such as Gen-R, an ex vivo genetic reprogramming technology to overcome T cell exhaustion; and Epi-R, an ex vivo epigenetic reprogramming technology to generate...
More about LYEL
Track This Portfolio

Track Mwg Management Ltd. Portfolio

Follow Mwg Management Ltd. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Mwg Management Ltd., based on Form 13F filings with the SEC.

News

Stay updated on Mwg Management Ltd. with notifications on news.